Metis Global Partners LLC Has $1.60 Million Stock Position in Centene Co. (NYSE:CNC)

Metis Global Partners LLC increased its position in shares of Centene Co. (NYSE:CNC) by 2.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,230 shares of the company’s stock after purchasing an additional 497 shares during the quarter. Metis Global Partners LLC’s holdings in Centene were worth $1,598,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Park Place Capital Corp increased its stake in Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after acquiring an additional 357 shares during the last quarter. WR Wealth Planners LLC increased its stake in shares of Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after purchasing an additional 137 shares during the last quarter. Chris Bulman Inc bought a new stake in shares of Centene during the 2nd quarter worth $33,000. Riverview Trust Co boosted its stake in Centene by 154.6% in the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after buying an additional 320 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new position in Centene in the second quarter valued at about $36,000. 93.63% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CNC has been the topic of a number of research analyst reports. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Robert W. Baird decreased their target price on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Stephens reiterated an “equal weight” rating and set a $78.00 price target on shares of Centene in a report on Monday, August 5th. Jefferies Financial Group lowered Centene from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $83.00 to $69.00 in a research report on Wednesday, July 24th. Finally, Barclays dropped their target price on Centene from $97.00 to $91.00 and set an “overweight” rating for the company in a research report on Tuesday, October 29th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Centene currently has a consensus rating of “Moderate Buy” and an average target price of $83.92.

Insider Transactions at Centene

In other news, CEO Sarah London bought 4,117 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the acquisition, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Andrew Lynn Asher purchased 17,200 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were acquired at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now owns 486,847 shares in the company, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.33% of the company’s stock.

Centene Price Performance

Centene stock opened at $57.46 on Friday. The firm has a market cap of $29.01 billion, a P/E ratio of 9.98, a P/E/G ratio of 0.80 and a beta of 0.49. The stock’s 50 day moving average is $68.06 and its 200 day moving average is $71.01. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Co. has a one year low of $57.25 and a one year high of $81.42.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.